-2.9 | | MPI | '154; 1 micromolar' vs 'DMSO' | compound | Development of a small molecule for treatment of castration resistant prostate cancer via androgen receptor and IL6/STAT3 pathways |
-2.6 | | MPI | 'Digoxin; 400 nanomolar' vs 'DMSO' | compound | Expression profiling of Jurkat cells infected with HIV-1 and treated with digoxin or DMSO |
-2.6 | | MPI | 'P-bodies (cytosolic RNP granules)' vs 'pre-sorted fraction' | fraction | RNA-Seq of purified P-bodies from HEK293 cells |
-2.5 | | MPI | 'non-small cell lung carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-2.3 | | MPI | "after autologous stem cell transplantation" vs "before autologous stem cell transplantation" | time | RNA-seq of human multiple myeloma patients myeloid-derived suppressor cells (M-MDSC) |
-2.2 | | MPI | 'CCNK knock-down' vs 'mock' | RNA interference | RNA-seq analysis of vorinostat-resistant HCT116 cells following gene knockdown of potential vorinostat-resistance candidate genes |
-2.2 | | MPI | 'colorectal carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-2.1 | | MPI | 'breast carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-2.1 | | MPI | 'pancreatic adenocarcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
2.1 | | MPI | 'erythroleukemia; ZRSR2 shRNA' vs 'normal' | disease, genotype | RNA-seq of bone marrow from patients with myelodysplastic syndrome |
2 | | MPI | 'Snail overexpression' vs 'control' | treatment | Expression data from breast cancer cell line MCF-7 with ectopic expression of the transcription factor Snail |
1.9 | | MPI | 'control media in hypoxia (1% pO2)' vs 'control' | growth condition | The genomic analysis of the interaction between the lactic acidosis and hypoxia response |
-1.9 | | MPI | 'deferoxamine; HIF-1a siRNA' vs 'deferoxamine; none' | growth condition, treatment | Transcription profiling by array of human glioblastoma cells after stimulation with deferoxamine and treatment with polyamide 1, echinomycin, or HIF-1a siRNA |
-1.9 | | MPI | '154; 0.4 micromolar' vs 'DMSO' | compound | Development of a small molecule for treatment of castration resistant prostate cancer via androgen receptor and IL6/STAT3 pathways |
-1.8 | | MPI | 'deferoxamine; 100 nanomolar echinomycin' vs 'deferoxamine; none' | growth condition, treatment | Transcription profiling by array of human glioblastoma cells after stimulation with deferoxamine and treatment with polyamide 1, echinomycin, or HIF-1a siRNA |
1.8 | | MPI | 'hypoxia' vs 'normoxia' in 'SNF96.2' | cell line, growth condition | Hypoxia and Intrinsic Transcriptomic Subtyping of Soft Tissue Sarcoma |
-1.7 | | MPI | 'GLV-1h153' at '24 hour' vs 'control' | infect, time | Expression data from human pancreatic cells PANC-1 infected with oncolytic vaccinia virus GLV-1h153 |
-1.7 | | MPI | 'glioblastoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
1.7 | | MPI | 'psoriasis' vs 'normal' in 'Ovation RNA Amplification V2 kit' | disease, protocol | Dominant Th1 and Minimal Th17 Skewing in Discoid Lupus Revealed by Transcriptomic Comparison with Psoriasis |
1.6 | | MPI | 'cisplatin; 100 micromolar' vs 'none' in 'scrambled siRNA' | RNA interference, compound | RNA-seq of human head and neck cancer cell line SQD9 knock-out for TMEM45A exposed to cisplatin |
1.5 | | MPI | 'hypoxia' vs 'normoxia' in '93T449' | cell line, growth condition | Hypoxia and Intrinsic Transcriptomic Subtyping of Soft Tissue Sarcoma |
-1.5 | | MPI | 'metastasis; tumor' vs 'metastasis; normal adjacent tissue' | clinical information, sampling site | Gene expression profile of primary colorectal tumors with and without distant metastasis |
-1.5 | | MPI | 'neuregulin' vs 'none' at '24 hour' | compound, time | Expression data from MCF7 cells treated with Neuregulin (NRG) at different times |
-1.4 | | MPI | 'EX00000246; stimulated with interferon gamma and lipopolysaccharide' vs 'none' at '24 hour' | compound, time, treatment | GPBAR1 agonism has a broad impact on blocking macrophage activation |
1.4 | | MPI | '3 to 5 weeks post ovulation' vs 'adult' in 'normal' | developmental stage, disease | Comparison of gene expression profiling of human lung at four developmental stages and lung adenocarcioma |
-1.4 | | MPI | 'heat-killed Escherichia coli' vs 'none' in 'ulcerative colitis' | disease, stimulus | Transcription profiling by array of primary human macrophages cultured from patients with ulcerative colitis or healthy individuals with or without stimulation by heat-killed E. coli |
-1.4 | | MPI | '3 h DRB 0 min 4sU' vs 'untreated' | treatment | 4sUDRB-seq: measuring transcription elongation and initiation genomewide |
-1.4 | | MPI | 'ochratoxin A; 130 nanomolar' vs 'none' at '3 day' | compound, time | Microarray mRNA data of RPTEC/TERT1 cells exposed to nephrotoxic chemicals ochratoxin A and potassium bromate |
1.4 | | MPI | 'astrocyte overexpressing 4 genes' vs 'glioblastoma cell line' | phenotype | Transcription profiling by array of human primary astrocytes, cancer stem cells derived from astrocytes overexpressing various oncogenic and iPSC-inducing factors, glioma stem cells and gliblastomat cell line to compare their expression profiles and tumor-initiating capabilities |
-1.4 | | MPI | 'shco4 shRNA targeting Coco' vs 'control' | RNA interference | Gene expression data from MDA-MB231 cells stably transduced with lentiviral vectors encoding a control shRNA (shscramble) or two shRNAs targeting Coco (shco2 and shco4) |
1.4 | | MPI | 'activated B cell' vs 'memory B cell' | cell type | Transcription profiling by array of human activated B cells, plasmablasts and plasma cells compared to memory B cells |
1.3 | | MPI | 'cisplatin; 100 micromolar' vs 'none' in 'TMEM45A knockdown by siRNA' | RNA interference, compound | RNA-seq of human head and neck cancer cell line SQD9 knock-out for TMEM45A exposed to cisplatin |
-1.3 | | MPI | 'DMSO' in 'stimulated with interferon gamma and lipopolysaccharide' vs 'none' at '24 hour' | compound, time, treatment | GPBAR1 agonism has a broad impact on blocking macrophage activation |
-1.3 | | MPI | 'RNPS1 knockdown' vs 'wild type phenotype' | phenotype | RNA-Seq of control, RNPS1 knockdown and rescue in HeLa cells |
-1.3 | | MPI | 'RNPS1 knockdown and rescue with RNPS1 loss of function mutant' vs 'wild type phenotype' | phenotype | RNA-Seq of control, RNPS1 knockdown and rescue in HeLa cells |
-1.3 | | MPI | 'systemic-onset juvenile idiopathic arthritis; placebo, Prednisone, non-steroidal anti-inflammatory drug, methotrexate' vs 'normal; none' | disease, treatment | Gene expression data of whole blood of systemic juvenile idiopathic arthritis (SJIA) patients treated with canakinumab or placebo and age matched healthy controls |
1.3 | | MPI | 'NCI-H460; large cell lung carcinoma; P04' vs 'NCI-H460; large cell lung carcinoma; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-1.3 | | MPI | 'SARS coronavirus Urbani ΔORF6 mutant' vs 'mock' at '54 hour' | infect, time | Time course analysis of icSARS CoV Urbani or icSARS deltaORF6 infected Calu-3 2B4 bronchial epithelial cells |
1.3 | | MPI | 'early mesodermal progenitors' vs 'undifferentiated cells' | population | Expression data from undifferentiated human embryonic stem cells (hESC) and Day 3.5 mesodermal progenitor (CD326neg CD56+) population |
-1.3 | | MPI | 'ochratoxin A; 130 nanomolar' vs 'none' at '5 day' | compound, time | Microarray mRNA data of RPTEC/TERT1 cells exposed to nephrotoxic chemicals ochratoxin A and potassium bromate |
-1.3 | | MPI | 'heat-killed Escherichia coli' vs 'none' in 'normal' | disease, stimulus | Transcription profiling by array of primary human macrophages cultured from patients with ulcerative colitis or healthy individuals with or without stimulation by heat-killed E. coli |
1.3 | | MPI | 'astrocyte overexpressing 4 genes' vs 'astrocyte' | phenotype | Transcription profiling by array of human primary astrocytes, cancer stem cells derived from astrocytes overexpressing various oncogenic and iPSC-inducing factors, glioma stem cells and gliblastomat cell line to compare their expression profiles and tumor-initiating capabilities |
-1.3 | | MPI | 'metastatic recurrence; tumor' vs 'metastatic recurrence; normal adjacent tissue' | clinical information, sampling site | Gene expression profile of primary colorectal tumors with and without distant metastasis |
-1.3 | | MPI | 'Neisserial ligand MafA' vs 'none' | infect, stimulus | Transcriptome analysis of human brain microvascular endothelial cells response to Neisseria meningitidis and its antigen MafA using RNA-seq |
-1.2 | | MPI | '5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide; 0.4 millimolar' vs 'none' | compound | Transcriptome of primary acute myeloid leukemia (AML) cells treated with AICAr |
-1.2 | | MPI | 'THZ1 (35 nanomolar)' vs 'none' | compound | RNA-seq of IMR-5/75 neuroblastoma cell line treated with JQ1, THZ1 or combination against untreated controls |
1.2 | | MPI | 'MDAMB231; cocultured with fibroblast HFF1' vs 'MDAMB231; normal' | cell line, growth condition | System-Wide Analysis Reveals a Complex Network of Tumor-Fibroblast Interactions Involved in Tumorigenicity |
-1.2 | | MPI | 'DMSO-mediated cell differentiation prior to experiment' vs 'not cultured with DMSO' in 'none' | compound, growth condition | RNA-microarray analysis of PLB-985 cells cultured with or without interferon-gamma under both conditions that induce or do not induce cell differentiation |
-1.2 | | MPI | 'SARS coronavirus Urbani ΔORF6 mutant' vs 'mock' at '48 hour' | infect, time | Time course analysis of icSARS CoV Urbani or icSARS deltaORF6 infected Calu-3 2B4 bronchial epithelial cells |
-1.2 | | MPI | 'ochratoxin A; 130 nanomolar' vs 'none' at '1 day' | compound, time | Microarray mRNA data of RPTEC/TERT1 cells exposed to nephrotoxic chemicals ochratoxin A and potassium bromate |
1.2 | | MPI | '3 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
1.2 | | MPI | '10 unit per milliliter; JFHA' vs 'control' | compound | Primary human hepatocytes treated with IL28B and the HCV JFH1 Genotype 2A clone. |
-1.2 | | MPI | 'PARK2 overexpression' vs 'control' | genotype | Expression data from PARK2 overexpression in U251 cells |
-1.2 | | MPI | 'BRD4 inhibitor JQ1' vs 'none' in '92' | cell line, compound | Transcription profiling by array of uveal melanoma cell lines with wild type and mutant G-proteins (GNAQ or GNA11) in response to treatment with BRAD4 inhibitor JQ1 |
1.2 | | MPI | 'DAOY M14; MYC overexpression' vs 'DAOY; wild type' | cell type, genotype | Bone morphogenetic protein-7 is a MYC target with pro-survival functions in childhood medulloblastoma |
1.2 | | MPI | 'neoplasm' vs 'normal tissue adjacent to neoplasm' in 'clear cell renal cell carcinoma' | disease, sampling site | HLA ligand profiles of primary renal cell carcinoma maintained in metastases.sue |
1.2 | | MPI | 'hypoxia' vs 'normoxia' in 'SW684' | cell line, growth condition | Hypoxia and Intrinsic Transcriptomic Subtyping of Soft Tissue Sarcoma |
-1.1 | | MPI | 'PRPF8' vs 'control' | RNA interference | Regulation of constitutive and alternative messenger RNA splicing across the human transcriptome by PRPF8 is determined by 5' splice site strength |
1.1 | | MPI | 'KLF17 overexpression' at '5 day' vs 'wild type' at '0 day' | phenotype, time | RNA-seq of hESCs undergoing primed to naive-like resetting via exogenous KLF17 overexpression |
-1.1 | | ENSG00000178802 | 'colon adenocarcinoma' vs 'normal' | disease | RNA-seq of 21 sessile serrated colon adenoma/polyps, 10 hyperplastic polyps, 10 adenomas, 21 uninvolved colon and 20 control colon specimens |
-1.1 | | MPI | 'sulforaphane; normal' at '6 hour' vs 'DMSO; normal' at '6 hour' | compound, disease, time | Genome-wide transcriptome analysis of the dietary chemopreventive phytochemical sulforaphane on normal and prostate cancer cells. |
-1.1 | | ENSG00000178802 | 'lipopolysaccharide' vs 'none' in 'systemic-onset juvenile idiopathic arthritis' | disease, stimulus | A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis [RNA-Seq] |
-1.1 | | MPI | 'ejaculatory azoospermia; Johnsen score count 5' vs 'normal; Johnsen score count 10' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
-1.1 | | MPI | 'esophageal adenocarcinoma' vs 'Barrett’s esophagus; low-grade dysplasia' | disease, disease staging | Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's |
-1.1 | | MPI | 'HOP-62; adenocarcinoma of lung; P10' vs 'HOP-62; adenocarcinoma of lung; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-1.1 | | MPI | 'JQ1 (1 micromolar) and THZ1 (35 nanomolar)' vs 'none' | compound | RNA-seq of IMR-5/75 neuroblastoma cell line treated with JQ1, THZ1 or combination against untreated controls |
-1.1 | | MPI | 'SARS coronavirus Urbani ΔORF6 mutant' vs 'mock' at '60 hour' | infect, time | Time course analysis of icSARS CoV Urbani or icSARS deltaORF6 infected Calu-3 2B4 bronchial epithelial cells |
-1.1 | | MPI | 'SARS coronavirus Urbani' vs 'mock' at '36 hour' | infect, time | Time course analysis of icSARS CoV Urbani or icSARS deltaORF6 infected Calu-3 2B4 bronchial epithelial cells |
1.1 | | MPI | '10 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
1.1 | | MPI | '8 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
-1.1 | | MPI | 'DMSO-mediated cell differentiation prior to experiment' vs 'not cultured with DMSO' in 'interferon gamma' | compound, growth condition | RNA-microarray analysis of PLB-985 cells cultured with or without interferon-gamma under both conditions that induce or do not induce cell differentiation |
-1.1 | | MPI | 'phorbol 13-acetate 12-myristate; 100 nanomolar; lipopolysaccharide and interferon gamma; 1 day' vs 'none; none; 0 day' | compound, stimulus, time | Transcriptional profiling of THP1-derived human macrophages with different stimuli |
-1.1 | | MPI | 'COLO 205; adenocarcinoma of colon; P04' vs 'COLO 205; adenocarcinoma of colon; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
1.1 | | MPI | 'Hypoxia' vs 'Normoxia' in 'A2780; Cisplatin' | cell line, compound, growth condition | Analysis of gene expression changes in response to hypoxia and/or cisplatin in A2780 and A2780cis cells |
-1.1 | | MPI | 'shHOXA9; GBML18; ' vs 'control; GBML18; ' | RNA interference, cell line, phenotype | HOXA9 transcriptomic analysis in GBM cell lines (U87MG, U251 and primary GBML18) and in immortalized human astrocytes (hTERT/E6/E7) |
1.1 | | MPI | 'astrocyte overexpressing 4 genes' vs 'glioma stem cell line' | phenotype | Transcription profiling by array of human primary astrocytes, cancer stem cells derived from astrocytes overexpressing various oncogenic and iPSC-inducing factors, glioma stem cells and gliblastomat cell line to compare their expression profiles and tumor-initiating capabilities |
1.1 | | MPI | '7 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
1.1 | | MPI | 'deferoxamine; none' vs 'control; none' | growth condition, treatment | Transcription profiling by array of human glioblastoma cells after stimulation with deferoxamine and treatment with polyamide 1, echinomycin, or HIF-1a siRNA |
-1.1 | | MPI | 'hepatobiliary carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-1.1 | | MPI | 'West Nile Virus protein E domain DIII' at '6 hour' vs 'none' at '0 hour' | stimulus, time | Transcriptome analysis of human brain microvascular endothelial cells response to interactive DIII domain of protein E of WNV and interactive DIII domain of protein E of TBEV using RNA-seq |
-1.1 | | ENSG00000178802 | 'COVID-19' vs 'normal' in 'colon' | disease, organism part | Lung and colon transcriptome profiling of fatal COVID-19 cases |
1.1 | | MPI | 'type 1 diabetes clinical onset; pancreas' vs 'normal; pancreas' | clinical information, organism part | Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding) |
1.1 | | MPI | 'clear cell renal carcinoma' vs 'normal' in 'adult' | developmental stage, disease | Gene expression data from human data of different types of renal tumors and normal kidneys |
1.1 | | MPI | 'overexpression of HO-1' vs 'control' in '0 nanogram per milliliter; tumor necrosis factor' | compound, phenotype | HO-1 modulates the expression of genes involved in inflammation, angiogenesis, proliferation, apoptosis and cell adhesion in human lung cancer cells. |
1 | | MPI | 'RRx-1; 20 micromolar' vs 'none' | compound | RNA-seq of Huh7 cell after G6PD enzyme activity inhibitor RRx-1 treated with 20μM concentrations for 24h |
-1 | | ENSG00000178802 | 'bacteriemia; Staphylococcus aureus' vs 'normal; none' | disease, infect | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
1 | | MPI | 'KLF17 overexpression' vs 'wild type' at '5 day' | phenotype, time | RNA-seq of hESCs undergoing primed to naive-like resetting via exogenous KLF17 overexpression |
1 | | MPI | 'sulforaphane; normal' at '24 hour' vs 'DMSO; normal' at '24 hour' | compound, disease, time | Genome-wide transcriptome analysis of the dietary chemopreventive phytochemical sulforaphane on normal and prostate cancer cells. |
1 | | MPI | 'neoplasm' vs 'normal tissue adjacent to neoplasm' in 'smoker; non-obese' | clinical history, clinical information, sampling site | Smoking and Obesity Related Molecular Alterations in Clear Cell Renal Cell Carcinoma |
-1 | | MPI | 'acquired TRAIL-resistance' vs 'control' | genotype | Gene expression profile of TRAIL-sensitive and -resistant H460 cells |
1 | | MPI | 'NCI-H460; large cell lung carcinoma; P01' vs 'NCI-H460; large cell lung carcinoma; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-1 | | MPI | 'DDX3 siRNA 8' vs 'scrambled siRNA' | RNA interference | Expression profiling of DDX3X and DDX54 knockdown in MCF7 cells |
-1 | | MPI | 'FOXP3 expression' vs 'doxycycline-mediated repression of FOXP3' in 'control siRNA' | RNA interference, phenotype | Transcription profiling by array of human MCF-7 breast cancer cells with FOXP3 target gene expression with and without MOF knockdown |
1 | | MPI | 'NCI-H460; large cell lung carcinoma; P10' vs 'NCI-H460; large cell lung carcinoma; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-1 | | MPI | 'SARS coronavirus Urbani ΔORF6 mutant' vs 'mock' at '72 hour' | infect, time | Time course analysis of icSARS CoV Urbani or icSARS deltaORF6 infected Calu-3 2B4 bronchial epithelial cells |
-1 | | MPI | 'Cisplatin' vs 'None' in 'A2780; Normoxia' | cell line, compound, growth condition | Analysis of gene expression changes in response to hypoxia and/or cisplatin in A2780 and A2780cis cells |
-1 | | MPI | 'Staphylococcus aureus strain SK2' vs 'none' | infect | Transcription profiling of human primary bone cells exposed to Staphylococcus aureus |
1 | | MPI | 'brefeldin A' vs 'ethanol' at '20 hour' | compound, time | Microarray analysis of human A549 lung cancer cells treated with brefeldin A, golgicide A, monensin or vehicle control for 8 h or 20 h |
-1 | | MPI | 'DMSO-mediated cell differentiation during experiment' vs 'not cultured with DMSO' in 'none' | compound, growth condition | RNA-microarray analysis of PLB-985 cells cultured with or without interferon-gamma under both conditions that induce or do not induce cell differentiation |
-1 | | MPI | 'human metapneumovirus' at '72 hour' vs 'none' at '48 hour' | infect, time | Transcription profiling by array of human bronchiole epithelial cells infected with human metapneumovirus |
1 | | MPI | 'astrocyte overexpressing 7 genes' vs 'glioblastoma cell line' | phenotype | Transcription profiling by array of human primary astrocytes, cancer stem cells derived from astrocytes overexpressing various oncogenic and iPSC-inducing factors, glioma stem cells and gliblastomat cell line to compare their expression profiles and tumor-initiating capabilities |
1 | | MPI | 'MPS-1 shRNA' vs 'control shRNA' | RNA interference | Transcription profiling by array of metallopanstimulin-1 (MPS-1) knock down human gastric cancer cells |
1 | | MPI | 'cultured with 3D BPH-1 epithelial acini' vs 'cultured without epithelial acini' | growth condition | Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells |
-1 | | MPI | 'liver' vs 'blood' in 'mucosal invariant T cell; Uveal Melanoma' | cell type, disease, organism part | RNA-seq expression profiling of humain MAIT cells in blood and liver as compared to mainstream TCD4+ and TCD8+ cells. |
1 | | MPI | '9 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
1 | | MPI | 'hypoxia' vs 'normal atmospheric oxygen pressure' in 'high metastatic cell line' | growth condition, phenotype | Transcriptome analysis of pancreatic cancer cell line that differ in metastatic potential |
-1 | | MPI | 'T-helper 2 polarising' at '5 days' vs 'no stimulus' | cell type, sampling time point, stimulus | Transcription profiling by array of human CD4+T-cells, Th1/Th2 polarized time-series and primary memory subsets |
-1 | | MPI | 'tumor necrosis factor alpha' vs 'none' in 'brain microvascular endothelial cell; co-culture' | cell type, growth condition, stimulus | Reactive astrocytes transduce blood-brain barrier inflammation through a TNFα-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin |
1 | | MPI | '48 hour' vs '0 hour' in 'cytomegalovirus infection' | time | Transcriptome modulation analysis of cytomegalovirus-infected immature monocyte-derived dendritic cells |
1 | | MPI | 'intravenous immunoglobulin and methylprednisolone' vs 'none' in 'intravenous immunoglobulin resistant' | clinical treatment, phenotype | Transcription profiling by array of human peripheral blood samples from Kawasaki disease patients after treatment with intravenous immunoglobulin and methylprednisolone |
-1 | | MPI | 'U87MG; MSCV-HOXA9' vs 'U87MG; control' | RNA interference, cell line, phenotype | HOXA9 transcriptomic analysis in GBM cell lines (U87MG, U251 and primary GBML18) and in immortalized human astrocytes (hTERT/E6/E7) |
-0.6 | | ENSG00000178802 | 'Alzheimer's disease' vs 'normal' in 'octogenarian age bracket' | disease, clinical information | Proteomics of Brain Proteome Revealed Altered Mitochondrial Function in Alzheimer Disease |
